Upload Avatar (500 x 500)
Wei Lai
Clinical Medicine
Tsinghua University
Beijing
Language: English, Chinese
Non-Alcoholic Fatty Liver Disease
Diagnosis
Liver
Fatty Liver
Hepatitis B
Chronic Hepatitis
Antiviral Treatment
Liver Disease
Medical Research
Clinical Studies
Areas of Focus
- Diagnosis of Non-Alcoholic Fatty Liver Disease
- Antiviral Treatment of Chronic Hepatitis B
Work Experience
- 1983.7-2000.10 - Xuzhou Medical College Affiliated Hospital - Role not mentioned
- 2000.11-2019.2 - Peking University People's Hospital - Role not mentioned
- 2019.3-Present - Beijing Tsinghua Changgung Hospital - Role not mentioned
Academic Background & Achievements
- 1978.10-1983.7 Bachelor's Degree: Xuzhou Medical College
- 1986.9-1989.6 Master's Degree: Xuzhou Medical College
- 1993.9-1996.6 Doctoral Degree: Peking Medical University
- Achievement: Established optimized treatment plan for chronic hepatitis C included in WHO and APASL guidelines
- Achievement: Developed a multi-dimensional parameter analysis system for non-alcoholic fatty liver disease
Publications
- Sofosbuvir-velpatasvir for treatment of chronic hepatitis C virus infection in Asia: a single-arm, open-label, phase 3 trial, Wei Lai, 2019
- Hepatitis B Virus Virions Produced Under Nucleos(t)ide Analogue Treatment Are Mainly Not Infectious Because of Irreversible DNA Chain Termination, Wei Lai, 2020
- qFIBS: An Automated Technique for Quantitative Evaluation of Fibrosis, Inflammation, Ballooning, and Steatosis in Patients With Nonalcoholic Steatohepatitis, Wei Lai, 2020
- Glecaprevir-pibrentasvir to treat chronic hepatitis C virus infection in Asia: two multicentre, phase 3 studies- a randomised, double-blind study (VOYAGE-1) and an open-label, single-arm study (VOYAGE-2), Wei Lai, 2020
Awards
- Second Prize of Chinese Medical Science and Technology Progress Award: Detail not mentioned
- Second Prize of Ministry of Education Science and Technology Progress Award: Detail not mentioned
